Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 189

1.

Integrating Publicly Available Data to Generate Computationally Predicted Adverse Outcome Pathways for Fatty Liver.

Bell SM, Angrish MM, Wood CE, Edwards SW.

Toxicol Sci. 2016 Apr;150(2):510-20. doi: 10.1093/toxsci/kfw017. Epub 2016 Feb 19.

PMID:
26895641
2.

Clearance of bile and trypsin in rat lungs following aspiration of human gastric fluid.

Leung JH, Chang JC, Foltz E, Bell SM, Pi C, Azad S, Everett ML, Holzknecht ZE, Sanders NL, Parker W, Davis RD, Keshavjee S, Lin SS.

Exp Lung Res. 2016 Feb;42(1):37-43. doi: 10.3109/01902148.2016.1139213.

3.

The role of soluble and insoluble gastric fluid components in the pathogenesis of obliterative bronchiolitis in rat lung allografts.

Leung JH, Chang JC, Bell SM, Holzknecht ZE, Thomas SM, Everett ML, Parker W, Davis RD, Lin SS.

Transpl Int. 2016 Feb;29(2):253-61. doi: 10.1111/tri.12715. Epub 2015 Dec 17.

PMID:
26820489
4.

Patients who are not driving 6 weeks after transient ischaemic attack have higher levels of anxiety.

Bell SM, Maniam R, Patel A, Harkness K, Blackburn D.

Psychogeriatrics. 2016 Jan 27. doi: 10.1111/psyg.12194. [Epub ahead of print] No abstract available.

PMID:
26818414
5.

Accelerating Adverse Outcome Pathway Development Using Publicly Available Data Sources.

Oki NO, Nelms MD, Bell SM, Mortensen HM, Edwards SW.

Curr Environ Health Rep. 2016 Mar;3(1):53-63. doi: 10.1007/s40572-016-0079-y. Review.

PMID:
26809562
6.

Epidemiology of Intracerebral Haemorrhage.

Poon MT, Bell SM, Al-Shahi Salman R.

Front Neurol Neurosci. 2015;37:1-12. doi: 10.1159/000437109. Epub 2015 Nov 12.

PMID:
26588164
7.

An siRNA-based functional genomics screen for the identification of regulators of ciliogenesis and ciliopathy genes.

Wheway G, Schmidts M, Mans DA, Szymanska K, Nguyen TM, Racher H, Phelps IG, Toedt G, Kennedy J, Wunderlich KA, Sorusch N, Abdelhamed ZA, Natarajan S, Herridge W, van Reeuwijk J, Horn N, Boldt K, Parry DA, Letteboer SJ, Roosing S, Adams M, Bell SM, Bond J, Higgins J, Morrison EE, Tomlinson DC, Slaats GG, van Dam TJ, Huang L, Kessler K, Giessl A, Logan CV, Boyle EA, Shendure J, Anazi S, Aldahmesh M, Al Hazzaa S, Hegele RA, Ober C, Frosk P, Mhanni AA, Chodirker BN, Chudley AE, Lamont R, Bernier FP, Beaulieu CL, Gordon P, Pon RT, Donahue C, Barkovich AJ, Wolf L, Toomes C, Thiel CT, Boycott KM, McKibbin M, Inglehearn CF; UK10K Consortium; University of Washington Center for Mendelian Genomics, Stewart F, Omran H, Huynen MA, Sergouniotis PI, Alkuraya FS, Parboosingh JS, Innes AM, Willoughby CE, Giles RH, Webster AR, Ueffing M, Blacque O, Gleeson JG, Wolfrum U, Beales PL, Gibson T, Doherty D, Mitchison HM, Roepman R, Johnson CA.

Nat Cell Biol. 2015 Aug;17(8):1074-87. doi: 10.1038/ncb3201. Epub 2015 Jul 13.

8.

Identification and Prioritization of Relationships between Environmental Stressors and Adverse Human Health Impacts.

Bell SM, Edwards SW.

Environ Health Perspect. 2015 Nov;123(11):1193-9. doi: 10.1289/ehp.1409138. Epub 2015 Apr 10.

9.

Neutral endopeptidase-resistant C-type natriuretic peptide variant represents a new therapeutic approach for treatment of fibroblast growth factor receptor 3-related dwarfism.

Wendt DJ, Dvorak-Ewell M, Bullens S, Lorget F, Bell SM, Peng J, Castillo S, Aoyagi-Scharber M, O'Neill CA, Krejci P, Wilcox WR, Rimoin DL, Bunting S.

J Pharmacol Exp Ther. 2015 Apr;353(1):132-49. doi: 10.1124/jpet.114.218560. Epub 2015 Feb 3.

10.

Systematic Omics Analysis Review (SOAR) tool to support risk assessment.

McConnell ER, Bell SM, Cote I, Wang RL, Perkins EJ, Garcia-Reyero N, Gong P, Burgoon LD.

PLoS One. 2014 Dec 22;9(12):e110379. doi: 10.1371/journal.pone.0110379. eCollection 2014.

11.

Cerebral amyloid angiopathy: amyloid spells and cortical superficial siderosis.

Coates R, Bell SM, Coley S, Blackburn DJ.

Pract Neurol. 2015 Apr;15(2):124-6. doi: 10.1136/practneurol-2014-000952. Epub 2014 Oct 30. No abstract available.

PMID:
25359331
12.

Using the electronic health record to connect primary care patients to evidence-based telephonic tobacco quitline services: a closed-loop demonstration project.

Adsit RT, Fox BM, Tsiolis T, Ogland C, Simerson M, Vind LM, Bell SM, Skora AD, Baker TB, Fiore MC.

Transl Behav Med. 2014 Sep;4(3):324-32. doi: 10.1007/s13142-014-0259-y.

13.

Erythrocyte-mediated delivery of phenylalanine ammonia lyase for the treatment of phenylketonuria in BTBR-Pah(enu2) mice.

Rossi L, Pierigè F, Carducci C, Gabucci C, Pascucci T, Canonico B, Bell SM, Fitzpatrick PA, Leuzzi V, Magnani M.

J Control Release. 2014 Nov 28;194:37-44. doi: 10.1016/j.jconrel.2014.08.012. Epub 2014 Aug 23.

14.

Defining success in graduate school.

Bell SM, Blumstein J, Brose K, Carroll A, Chang J, Charles J, Haswell ES, Michelitsch M, Owens JC, Patil CK, Smith R, Tupy J, Walsh E, Ware T.

Mol Biol Cell. 2014 Jul 1;25(13):1942-4. doi: 10.1091/mbc.E14-03-0793.

15.

Deregulation of microcephalin and ASPM expression are correlated with epithelial ovarian cancer progression.

Alsiary R, Brüning-Richardson A, Bond J, Morrison EE, Wilkinson N, Bell SM.

PLoS One. 2014 May 15;9(5):e97059. doi: 10.1371/journal.pone.0097059. eCollection 2014.

16.

Development of an internal amplification control system for a real-time PCR assay for detection of Neisseria meningitidis in CSF and EDTA blood.

McIver CJ, Bell SM, Er N.

Pathology. 2014 Jun;46(4):344-7. doi: 10.1097/PAT.0000000000000098.

PMID:
24798157
17.

High-content, high-throughput screening for the identification of cytotoxic compounds based on cell morphology and cell proliferation markers.

Martin HL, Adams M, Higgins J, Bond J, Morrison EE, Bell SM, Warriner S, Nelson A, Tomlinson DC.

PLoS One. 2014 Feb 5;9(2):e88338. doi: 10.1371/journal.pone.0088338. eCollection 2014.

18.

Regulation of estrogen receptor β1 expression in breast cancer by epigenetic modification of the 5' regulatory region.

Al-Nakhle H, Smith L, Bell SM, Burns PA, Cummings M, Hanby AM, Lane S, Parker MD, Hughes TA, Speirs V.

Int J Oncol. 2013 Dec;43(6):2039-45. doi: 10.3892/ijo.2013.2112. Epub 2013 Sep 25.

PMID:
24068253
19.

A high-throughput assay to identify modifiers of premature chromosome condensation.

Adams M, Cookson VJ, Higgins J, Martin HL, Tomlinson DC, Bond J, Morrison EE, Bell SM.

J Biomol Screen. 2014 Jan;19(1):176-83. doi: 10.1177/1087057113495443. Epub 2013 Aug 27.

PMID:
23983231
20.

Limited diversity in the gene pool allows prediction of third-generation cephalosporin and aminoglycoside resistance in Escherichia coli and Klebsiella pneumoniae.

Ginn AN, Zong Z, Wiklendt AM, Thomas LC, Merlino J, Gottlieb T, van Hal S, Harkness J, Macleod C, Bell SM, Leroi MJ, Partridge SR, Iredell JR.

Int J Antimicrob Agents. 2013 Jul;42(1):19-26. doi: 10.1016/j.ijantimicag.2013.03.003. Epub 2013 May 21.

PMID:
23706544
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk